Spiro Rombotis
Overview
Spiro Rombotis received an average of $935K in total compensation, including $501K in salary, at Cyclacel Pharmaceuticals from 2006 to 2023.
2023Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2022Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2021Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2020Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2019Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2018Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2017Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2016Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2015Cyclacel PharmaceuticalsPresident and Chief Executive Officer
2014Cyclacel PharmaceuticalsPresident and Chief Executive Officer
Related executives
We found eight more executives who work or worked at Cyclacel Pharmaceuticals.
Mark Kirschbaum
Cyclacel Pharmaceuticals
Chief Medical Officer
Paul McBarron
Cyclacel Pharmaceuticals
Chief Financial Officer
Judy Chiao
Cyclacel Pharmaceuticals
Vice President, Clinical Development and Regulatory Affairs
Greg Reyes
Cyclacel Pharmaceuticals
Senior Vice President Research
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
Robert Jackson
Cyclacel Pharmaceuticals
Chief Scientific Officer
Robert Kirkman
Cyclacel Pharmaceuticals
Chief Executive Officer
Kathi Cordova
Cyclacel Pharmaceuticals
Former Senior Vice President of Finance and Treasurer
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020